Scale -


  • Ebitda is 0.07 Rs Cr; 5 Year CAGR is 15 %; Annual Decline is -36 %; Continuous Decline over 3 years; in Bottom Quartile
  • PBT is -0.02 Rs Cr; 5 Year CAGR is 15 %; Annual Decline is -36 %; in Bottom Quartile
  • PAT is 0.05 Rs Cr; Annual Decline is -44 %; Continuous Decline over 3 years; in Bottom Quartile
  • Revenue is 0.83 Rs Cr; in Bottom Quartile
  • Quarterly Revenue is 0.12 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is 8.12 %; in Top Quartile; 5 Year CAGR is 10 %; Annual Decline is -45 %
  • PAT Margin is 6.08 %; in Top Quartile; Annual Decline is -45 %; Continuous Decline over 3 years
  • Quarterly Profit margin is -17 %; Continuous Decline over 3 Quarters; in Bottom Quartile

Return -


  • ROCE is 2.57 %; Annual Decline is -42 %; Continuous Decline over 3 years
  • ROA is 1.87 %; Annual Decline is -42 %; Continuous Decline over 3 years
  • ROE is 1.92 %; Annual Decline is -42 %; Continuous Decline over 3 years
  • Asset Turnover is 31 %; in Bottom Quartile

Efficiency -


  • Current Ratio is 25.78; in Top Quartile
  • Quick Ratio is 25.78; in Top Quartile
  • Operating cash flow is -0.1 Rs Cr; Annual Decline is -100 %
  • Inventory Turnover Ratio is 0; in Bottom Quartile

Solvancy -


  • Total Debt is 0 Rs Cr; in Bottom Quartile

Quality -


  • Operating cashflow/ebitda is -143 %; Annual Decline is -214 %; in Bottom Quartile
  • Operating cashflow/PAT is -200 %; Annual Decline is -260 %; in Bottom Quartile
  • Current Tax/PAT is 40 %; Continuous Growth over 3 years; in Top Quartile
  • Other Expenses/Total Expenses is 13 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
SUDARSHAN PHARMA Stock/Share price , NSE/BSE Forecast News and Live Quotes